Effect of methanolic leaf extract on acalypha wilkesiana on weight parameters in paracetamol induced hepatoxicity in male rats
Table Of Contents
Chapter ONE
INTRODUCTION
- 1.1Introduction
- 1.2Background of Study
- 1.3Problem Statement
- 1.4Objective of Study
- 1.5Limitation of Study
- 1.6Scope of Study
- 1.7Significance of Study
- 1.8Structure of the Research
- 1.9Definition of Terms
Chapter TWO
LITERATURE REVIEW
- 2.1Overview of Methanolic Leaf Extracts
- 2.2Acalypha Wilkesiana: An Overview
- 2.3Paracetamol-Induced Hepatotoxicity
- 2.4Weight Parameters in Biological Studies
- 2.5Previous Research on Methanolic Leaf Extracts
- 2.6Previous Studies on Acalypha Wilkesiana
- 2.7Effects of Paracetamol on Liver Function
- 2.8Impact of Weight Parameters on Disease Progression
- 2.9Theoretical Framework for the Study
- 2.10Conceptual Framework for the Study
Chapter THREE
RESEARCH METHODOLOGY
- 3.1Research Design
- 3.2Sampling Methodology
- 3.3Data Collection Techniques
- 3.4Data Analysis Procedures
- 3.5Ethical Considerations
- 3.6Validity and Reliability
- 3.7Instrumentation
- 3.8Data Interpretation Techniques
Chapter FOUR
DATA PRESENTATION AND ANALYSIS
- 4.1Overview of Research Findings
- 4.2Analysis of Methanolic Leaf Extract Effects
- 4.3Impact on Weight Parameters in Rats
- 4.4Comparison with Control Group
- 4.5Discussion on Hepatoprotective Properties
- 4.6Implications for Future Research
- 4.7Recommendations for Practice
- 4.8Limitations of the Study
Chapter FIVE
SUMMARY, CONCLUSION AND RECOMMENDATIONS
- 5.1Summary of Findings
- 5.2Conclusion
- 5.3Implications for the Field
- 5.4Contributions to Knowledge
- 5.5Recommendations for Further Research
Project Abstract
The present study aimed to investigate the effect of methanolic leaf extract of Acalypha wilkesiana on weight parameters in male rats with paracetamol-induced hepatoxicity. Acalypha wilkesiana is known for its hepatoprotective properties due to its rich phytochemical composition. Paracetamol-induced hepatoxicity is a widely used model for studying liver damage in experimental animals. Male rats were divided into five groups Group I served as the normal control, Group II received paracetamol to induce hepatoxicity, Group III received silymarin as a standard drug, Group IV received methanolic leaf extract of Acalypha wilkesiana alone, and Group V received a combination of paracetamol and methanolic leaf extract of Acalypha wilkesiana. The treatment was administered for 14 days, and the rats were monitored for changes in body weight, liver weight, and liver weight-to-body weight ratio. The results indicated a significant decrease in body weight in the paracetamol-induced hepatoxicity group compared to the normal control group. However, treatment with methanolic leaf extract of Acalypha wilkesiana, both alone and in combination with paracetamol, showed a significant improvement in body weight compared to the hepatoxicity group. The group treated with silymarin also showed a similar improvement in body weight. Furthermore, the liver weight and liver weight-to-body weight ratio were found to be significantly increased in the paracetamol-induced hepatoxicity group, indicating liver damage. Treatment with methanolic leaf extract of Acalypha wilkesiana, either alone or in combination with paracetamol, resulted in a significant reduction in liver weight and liver weight-to-body weight ratio compared to the hepatoxicity group. Silymarin treatment also showed a similar decrease in these parameters. Overall, the findings suggest that methanolic leaf extract of Acalypha wilkesiana exerts a protective effect on weight parameters in male rats with paracetamol-induced hepatoxicity. The improvement in body weight and reduction in liver weight and liver weight-to-body weight ratio indicate the potential hepatoprotective properties of Acalypha wilkesiana. Further studies are warranted to elucidate the underlying mechanisms of action and to explore its therapeutic potential in liver diseases.
Project Overview